Concentration-dependent collateral sensitivity of cisplatin-resistant gastric cancer cell sublines

Biochemical and Biophysical Research Communications

Volumn 328, Issue 2, 2005, Pages 618-622

  Xu, Haidong ^a   Choi, Seok Min ^b   An, Chun San ^b   Min, Young Don ^b   Kim, Kweon Cheon ^b   Kim, Kyung Jong ^b   Choi, Cheol Hee ^a,b  

^a Chosun University   (South Korea)

^b Chosun University College of Medicine   (South Korea)

Author keywords

Antioxidant; Cisplatin; Collateral sensitivity; Cross resistance; Gastric cancer; Transporter

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CARBOPLATIN; CATALASE; CISPLATIN; DOXORUBICIN; EPTAPLATIN; FLUOROURACIL; GLYCOPROTEIN P; METALLOTHIONEIN; MITOMYCIN C; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL CULTURE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG SENSITIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; STOMACH CANCER;

EID: 13444269138     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.01.015     Document Type: Article

References (24)

1. J.A. Wils Current status of chemotherapy for advanced gastric cancer Anticancer Res. 7 1987 755 759
2. J.S. MacDonald, P.S. Schein, P.V. Woolley, T. Smythe, W. Ueno, D. Hoth, F. Smith, M. Boiron, C. Gisselbrecht, R. Brunet, and C. Lagarde 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer Ann. Intern. Med. 93 1980 533 536
3. J.D. Hainsworth, D.H. Johnson, and F.A. Greco Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience J. Clin. Oncol. 10 1992 912 922
4. A. Ohtsu, Y. Shimada, S. Yoshida, H. Saito, S. Seki, K. Morise, and M. Kurihara Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: report from the Japan Clinical Oncology Group (JCOG) Eur. J. Cancer 30 1994 2091 2093
5. H. Timmer-Bosscha, N.H. Mulder, and E.G. de Vries Modulation of cis-diamminedichloroplatinum(II) resistance: a review Br. J. Cancer 66 1992 227 238
6. K. Taniguchi, M. Wada, K. Kohno, T. Nakamura, T. Kawabe, M. Kawakami, K. Kagotani, K. Okumura, S. Akiyama, and M. Kuwano A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation Cancer Res. 56 1996 4124 4129
7. M. Komatsu, T. Sumizawa, M. Mutoh, Z.S. Chen, K. Terada, T. Furukawa, X.L. Yang, H. Gao, N. Miura, T. Sugiyama, and S. Akiyama Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance Cancer Res. 60 2000 1312 1316
8. H. Bier Circumvention of drug resistance in cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79 in vitro and in vivo Acta Otolaryngol. 111 1991 797 806
9. P.A. Andrews, M.P. Murphy, and S.B. Howell Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells Cancer Chemother. Pharmacol. 19 1987 149 154
10. T. Yasuno, T. Matsumura, T. Shikata, J. Inazawa, T. Sakabe, S. Tsuchida, T. Takahata, S. Miyairi, A. Naganuma, and T. Sawada Establishment and characterization of a cisplatin-resistant human neuroblastoma cell line Anticancer Res. 19 1999 4049 4057
11. A.J. Kraker, and C.W. Moore Elevated DNA polymerase beta activity in a cis-diamminedichloroplatinum(II) resistant P388 murine leukemia cell line Cancer Lett. 38 1988 307 314
12. C.P. LeBel, H. Ischiropoulos, and S.C. Bondy Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress Chem. Res. Toxicol. 5 1992 227 231
13. T. Tsuruo, T.C. Hamilton, K.G. Louie, B.C. Behrens, R.C. Young, and R.F. Ozols Collateral susceptibility of adriamycin-, melphalan- and cisplatin-resistant human ovarian tumor cells to bleomycin Jpn. J. Cancer Res. 77 1986 941 945
14. F.M. Schabel Jr., H.E. Skipper, M.W. Trader, W.R. Laster Jr., D.P. Griswold Jr., and T.H. Corbett Establishment of cross-resistance profiles for new agents Cancer Treat. Rep. 67 1983 905 922
15. Y. Minagawa, J. Kigawa, H. Itamochi, and N. Terakawa The role of topoisomerase I inhibitor in cisplatin-resistant ovarian cancer Hum. Cell 14 2001 237 243
16. Y. Liang, L. O'Driscoll, S. McDonnell, P. Doolan, I. Oglesby, K. Duffy, R. O'Connor, and M. Clynes Enhanced in vitro invasiveness and drug resistance with altered gene expression patterns in a human lung carcinoma cell line after pulse selection with anticancer drugs Int. J. Cancer 111 2004 484 493
17. K.A. Conklin Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects Nutr. Cancer 37 2000 1 18
18. A. Miyajima, J. Nakashima, M. Tachibana, K. Nakamura, M. Hayakawa, and M. Murai N-Acetylcysteine modifies cis-dichlorodiammineplatinum-induced effects in bladder cancer cells Jpn. J. Cancer Res. 90 1999 565 570
19. K. Nakayama, K. Miyazaki, A. Kanzaki, M. Fukumoto, and Y. Takebayashi Expression and cisplatin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines Oncol. Rep. 8 2001 1285 1287
20. A. Kanzaki, M. Toi, N. Neamati, H. Miyashita, M. Oubu, K. Nakayama, H. Bando, K. Ogawa, M. Mutoh, S. Mori, K. Terada, T. Sugiyama, M. Fukumoto, and Y. Takebayashi Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma Jpn J. Cancer Res. 93 2002 70 77
21. M. Ohbu, K. Ogawa, S. Konno, A. Kanzaki, K. Terada, T. Sugiyama, and Y. Takebayashi Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human gastric carcinoma Cancer Lett. 189 2003 33 38
22. H. Miyashita, Y. Nitta, S. Mori, A. Kanzaki, K. Nakayama, K. Terada, T. Sugiyama, H. Kawamura, A. Sato, H. Morikawa, K. Motegi, and Y. Takebayashi Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin Oral Oncol. 39 2003 157 162
23. M. Higashimoto, A. Kanzaki, T. Shimakawa, S. Konno, Y. Naritaka, Y. Nitta, S. Mori, S. Shirata, A. Yoshida, K. Terada, T. Sugiyama, K. Ogawa, and Y. Takebayashi Expression of copper-transporting P-type adenosine triphosphatase in human esophageal carcinoma Int. J. Mol. Med. 11 2003 337 341
24. H. Sugeno, Y. Takebayashi, M. Higashimoto, Y. Ogura, G. Shibukawa, A. Kanzaki, K. Terada, T. Sugiyama, K. Watanabe, R. Katoh, Y. Nitta, T. Fukushima, Y. Koyama, N. Inoue, K. Sekikawa, K. Ogawa, Y. Sato, and S. Takenoshita Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) in human hepatocellular carcinoma Anticancer Res. 24 2004 1045 1048